Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation

PY Law and C Bergsbaken

Department of Pharmacology, University of Minnesota, Minneapolis.

Neuroblastoma NS20Y cells possess a high density of stereoselective delta opioid receptors as determined by competition binding with 3H- diprenorphine and various opioid ligands. Scatchard analysis of [3H]diprenorphine saturation binding data revealed a Kd = 0.79 +/- 0.17 nM and Bmax = 370 +/- 50 fmol/mg protein. These opioid binding sites have highest affinity for delta opioid receptor selective agonists and lowest affinity for mu opioid receptor selective agonists. Agonist binding was sensitive to the presence of the monovalent cation, Na+. Activation of receptor with D-Ala2, D-Leu5-enkephalin (DADLE) resulted in dose-dependent inhibition of forskolin-stimulated intracellular [3H]cAMP accumulation, which was antagonized by (-)-naloxone but not (+)-naloxone. Relative potencies of various opioid agonists to inhibit intracellular cAMP production paralleled those observed in neuroblastoma x glioma NG108-15 hybrid cells. Pretreatment of NS20Y cells with pertussis toxin (PTX) eliminated opioid agonist inhibition of adenylyl cyclase activity. Chronic DADLE treatment resulted in desensitization and down-regulation of opioid receptor. An increase in intracellular [3H]cAMP level above the control was observed in the presence of naloxone after chronic DADLE treatment. Therefore, opioid binding sites in neuroblastoma NS20Y cells possess properties of the classical delta opioid receptor type. After neuroblastoma NS20Y was growth arrested by culturing the cells in serum-free medium for 72 hr, proliferation was reinitiated by addition of fetal calf serum (FCS), 0.01% to 12%, and was monitored by either [3H]thymidine incorporation or by dye viability assay. It was demonstrated that naloxone and naltriben but not Met5-enkephalin could attenuate FCS-induced proliferation in a dose-dependent manner. Naltriben was 54-fold more potent than naloxone to attenuate NS20Y proliferation. The maximal level of viable cells per well was reduced (35.2 +/- 1.9%) with no alteration in FCS concentration-dependent stimulation of growth. Similar inhibition by naloxone (37.3 +/- 2.7%) was observed with [3H]thymidine incorporation studies. This naloxone effect was serum concentration-dependent and could be blocked by culturing NS20Y cells in the presence of both naloxone and Met5-enkephalin. Although pretreatment of NS20Y cells with pertussis toxin could attenuate FCS- stimulated proliferation, naloxone effect on growth was not affected by pertussis toxin pretreatment. Furthermore, the naloxone effect was not NS20Y specific. A similar naloxone effect was observed with neuroblastoma N1E115, although not with neuroblastoma x glioma NG108- 15, nor human neuroblastoma SHSY5Y, cell lines that have been reported to contain delta opioid receptors. Therefore, activation of delta opioid receptor could modulate FCS-induced growth in some but not all neuroblastoma cell lines.

Volume 272, Issue 1, pp. 322-332, 01/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				I. Tegeder and G. Geisslinger Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369. [Abstract] [Full Text] [PDF]

				K. Gupta, S. Kshirsagar, L. Chang, R. Schwartz, P.-Y. Law, D. Yee, and R. P. Hebbel Morphine Stimulates Angiogenesis by Activating Proangiogenic and Survival-promoting Signaling and Promotes Breast Tumor Growth Cancer Res., August 1, 2002; 62(15): 4491 - 4498. [Abstract] [Full Text] [PDF]

				D. Smirnov, H.-J. Im, and H. H. Loh delta -Opioid Receptor Gene: Effect of Sp1 Factor on Transcriptional Regulation in Vivo Mol. Pharmacol., August 1, 2001; 60(2): 331 - 340. [Abstract] [Full Text] [PDF]

				C. Ventura, M. Maioli, G. Pintus, G. Gottardi, and F. Bersani Elf-pulsed magnetic fields modulate opioid peptide gene expression in myocardial cells Cardiovasc Res, March 1, 2000; 45(4): 1054 - 1064. [Abstract] [Full Text] [PDF]

				S. Cvejic and L. A. Devi Dimerization of the delta  Opioid Receptor:. IMPLICATION FOR A ROLE IN RECEPTOR INTERNALIZATION J. Biol. Chem., October 24, 1997; 272(43): 26959 - 26964. [Abstract] [Full Text] [PDF]

				C. Ventura and G. Pintus Opioid Peptide Gene Expression in the Primary Hereditary Cardiomyopathy of the Syrian Hamster. III. AUTOCRINE STIMULATION OF PRODYNORPHIN GENE EXPRESSION BY DYNORPHIN B J. Biol. Chem., March 7, 1997; 272(10): 6699 - 6705. [Abstract] [Full Text] [PDF]

				P. Y. Law, T. M. McGinn, K. M. Campbell, L. E. Erickson, and H.H. Loh Agonist Activation of delta -Opioid Receptor but not {micro}-Opioid Receptor Potentiates Fetal Calf Serum or Tyrosine Kinase Receptor-Mediated Cell Proliferation in a CellLine-Specific Manner Mol. Pharmacol., January 1, 1997; 51(1): 152 - 160. [Abstract] [Full Text]

				S. Cvejic, N. Trapaidze, C. Cyr, and L. A. Devi Thr[IMAGE], Located within the COOH-terminal Tail of the [IMAGE] Opiate Receptor, Is Involved in Receptor Down-regulation J. Biol. Chem., February 23, 1996; 271(8): 4073 - 4076. [Abstract] [Full Text] [PDF]